Gastroparesis News and Research

RSS
Gastroparesis, also called delayed gastric emptying, is a disorder in which the stomach takes too long to empty its contents. Normally, the stomach contracts to move food down into the small intestine for digestion. The vagus nerve controls the movement of food from the stomach through the digestive tract. Gastroparesis occurs when the vagus nerve is damaged and the muscles of the stomach and intestines do not work normally. Food then moves slowly or stops moving through the digestive tract.
Tranzyme reports positive results from TZP-102 Phase 2 study in diabetic patients with gastroparesis

Tranzyme reports positive results from TZP-102 Phase 2 study in diabetic patients with gastroparesis

Welchol plus metformin combination therapy reduces A1C, LDL-C levels in type 2 diabetes patients

Welchol plus metformin combination therapy reduces A1C, LDL-C levels in type 2 diabetes patients

First placebo-controlled clinical study results of BYETTA injection with Lantus presented at ADA 2010

First placebo-controlled clinical study results of BYETTA injection with Lantus presented at ADA 2010

Data shows Victoza produces greater reductions in A1c, body weight and FPG than Januvia

Data shows Victoza produces greater reductions in A1c, body weight and FPG than Januvia

Data on BYETTA and SYMLIN injections, BYDUREON drug candidate to be presented at ADA 2010

Data on BYETTA and SYMLIN injections, BYDUREON drug candidate to be presented at ADA 2010

DURATION-4 study tests superiority of BYDUREON as compared to other type 2 diabetes medications

DURATION-4 study tests superiority of BYDUREON as compared to other type 2 diabetes medications

Norgine to develop and commercialize Tranzyme's ulimorelin ghrelin agonist

Norgine to develop and commercialize Tranzyme's ulimorelin ghrelin agonist

Tranzyme Pharma to present data on prokinetic agent TZP-101 in GI recovery at ASCRS 2010

Tranzyme Pharma to present data on prokinetic agent TZP-101 in GI recovery at ASCRS 2010

Medtronic initiates U.S. clinical trial of RestoreSensor neurostimulator in chronic pain patients

Medtronic initiates U.S. clinical trial of RestoreSensor neurostimulator in chronic pain patients

FDA assigns BYDUREON new PDUFA action date of October 22, 2010

FDA assigns BYDUREON new PDUFA action date of October 22, 2010

Amylin, Eli Lilly and Alkermes reply to FDA complete response letter for BYDUREON NDA

Amylin, Eli Lilly and Alkermes reply to FDA complete response letter for BYDUREON NDA

Pacemaker in stomach can help treat severe stomach disorders and chronic vomiting

Pacemaker in stomach can help treat severe stomach disorders and chronic vomiting

NDA for BYDUREON: FDA issues complete response letter

NDA for BYDUREON: FDA issues complete response letter

Tranzyme Pharma's ulimorelin Phase 2 trial data selected for presentation at DDW 2010

Tranzyme Pharma's ulimorelin Phase 2 trial data selected for presentation at DDW 2010

Ipsen grants Rhythm exclusive global license for melanocortin and ghrelin programs

Ipsen grants Rhythm exclusive global license for melanocortin and ghrelin programs

Study shows ghrelin prevents acute liver damage, reduces oxidative stress and inflammation

Study shows ghrelin prevents acute liver damage, reduces oxidative stress and inflammation

AGA conference highlights emerging technologies for digestive and metabolic disorders

AGA conference highlights emerging technologies for digestive and metabolic disorders

USAN approves generic name "ulimorelin" for Tranzyme Pharma's TZP-101

USAN approves generic name "ulimorelin" for Tranzyme Pharma's TZP-101

Research team reports rare etiology of SMA syndrome

Research team reports rare etiology of SMA syndrome

Zassi Medical Evolutions forms new company to develop electrical stimulation technology

Zassi Medical Evolutions forms new company to develop electrical stimulation technology